Poster 32
- Kelley Tangredi
- Jun 3, 2023
- 1 min read
Updated: Jul 8, 2023
Treatment-Emergent Adverse Events in Patients Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab in an Open-Label Extension Clinical Trial
Authors: Amy S. Paller, Elaine C. Siegfried, Robert Sidbury, Benjamin Lockshin, Michael Cork, Andreas Pinter, Jing Xiao, Faisal A. Khokhar, Ashish Bansal, Randy Prescilla
Comments